These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 18186900)

  • 21. Study of the genotype-phenotype relationship in four cases of congenital erythropoietic porphyria.
    To-Figueras J; Badenas C; Mascaró JM; Madrigal I; Merino A; Bastida P; Lecha M; Herrero C
    Blood Cells Mol Dis; 2007; 38(3):242-6. PubMed ID: 17270473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A knock-in mouse model of congenital erythropoietic porphyria.
    Ged C; Mendez M; Robert E; Lalanne M; Lamrissi-Garcia I; Costet P; Daniel JY; Dubus P; Mazurier F; Moreau-Gaudry F; de Verneuil H
    Genomics; 2006 Jan; 87(1):84-92. PubMed ID: 16314073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fatal diffuse capillaritis after hematopoietic stem-cell transplantation for dyskeratosis congenita despite low-intensity conditioning regimen.
    Brazzola P; Duval M; Fournet JC; Gauvin F; Dalle JH; Champagne J; Champagne MA
    Bone Marrow Transplant; 2005 Dec; 36(12):1103-5; author reply 1105. PubMed ID: 16205731
    [No Abstract]   [Full Text] [Related]  

  • 25. Bone Marrow Transplantation in Congenital Erythropoietic Porphyria: Sustained Efficacy but Unexpected Liver Dysfunction.
    Besnard C; Schmitt C; Galmiche-Rolland L; Debray D; Fabre M; Molina T; Gouya L; Ged C; Castelle M; Cavazzana M; Magrin E; Neven B; Moshous D; Blanche S; Frémond ML
    Biol Blood Marrow Transplant; 2020 Apr; 26(4):704-711. PubMed ID: 31843562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.
    Barba P; Piñana JL; Valcárcel D; Querol L; Martino R; Sureda A; Briones J; Delgado J; Brunet S; Sierra J
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1439-46. PubMed ID: 19822304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two brothers with mild congenital erythropoietic porphyria due to a novel genotype.
    Berry AA; Desnick RJ; Astrin KH; Shabbeer J; Lucky AW; Lim HW
    Arch Dermatol; 2005 Dec; 141(12):1575-9. PubMed ID: 16365260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Congenital erythropoietic porphyria: a single-observer clinical study of 29 cases.
    Katugampola RP; Badminton MN; Finlay AY; Whatley S; Woolf J; Mason N; Deybach JC; Puy H; Ged C; de Verneuil H; Hanneken S; Minder E; Schneider-Yin X; Anstey AV
    Br J Dermatol; 2012 Oct; 167(4):901-13. PubMed ID: 22816431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Report of a novel Indian case of congenital erythropoietic porphyria and overview of therapeutic options.
    Pandey M; Mukherjee SB; Patra B; Kapoor S; Ged C; Aneja S; Seth A
    J Pediatr Hematol Oncol; 2013 May; 35(4):e167-70. PubMed ID: 23612387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunosuppressive therapy for acute porphyria: safety and efficacy in a patient with bone marrow failure.
    Field JJ; Giannone L; Bessler M; Blinder MA
    Pharmacotherapy; 2006 Nov; 26(11):1662-6. PubMed ID: 17064214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Allogeneic bone marrow transplantation in congenital erythropoietic porphyria. Gunther's disease].
    Lagarde C; Hamel-Teillac D; De Prost Y; Blanche S; Thomas C; Fischer A; Nordmann Y; Ged C; De Verneuil H
    Ann Dermatol Venereol; 1998 Feb; 125(2):114-7. PubMed ID: 9747227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid full engraftment and successful immune reconstitution after allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning in Omenn syndrome.
    Gozdzik J; Czogala W; Skoczen S; Krasowska-Kwiecien A; Wiecha O; Mordel A; Lesko E; Majka M; Kowalczyk D; Zembala M
    Pediatr Transplant; 2009 Sep; 13(6):760-5. PubMed ID: 18992055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allogeneic stem cell transplantation for myelodysplastic syndromes in children: a report from the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).
    Muñoz A; Díaz-Heredia C; Badell I; Bureo E; Gómez P; Martínez A; Verdeguer A; Pérez-Hurtado JM; Fernández-Delgado R; González-Vicent M; Maldonado MS
    Pediatr Hematol Oncol; 2009; 26(5):345-55. PubMed ID: 19579081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripheral blood versus bone marrow as a source of hematopoietic stem cells for allogeneic transplantation in children with class I and II beta thalassemia major.
    Ghavamzadeh A; Iravani M; Ashouri A; Mousavi SA; Mahdavi N; Shamshiri A; Hadjibabaie M; Namdar R; Nedaeifard L; Ghaffari H; Alimoghaddam K
    Biol Blood Marrow Transplant; 2008 Mar; 14(3):301-8. PubMed ID: 18275896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unrelated donor and HLA-identical sibling haematopoietic stem cell transplantation cure chronic granulomatous disease with good long-term outcome and growth.
    Soncini E; Slatter MA; Jones LB; Hughes S; Hodges S; Flood TJ; Barge D; Spickett GP; Jackson GH; Collin MP; Abinun M; Cant AJ; Gennery AR
    Br J Haematol; 2009 Apr; 145(1):73-83. PubMed ID: 19222467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of acquired severe aplastic anemia in pediatric patients with immunosuppression and allogeneic stem cell hematopoietic transplant].
    Barriga C F; Wietstruck P A; Becker K A; Zúñiga C P; Besa De C P; Alvarez Z M; Ocqueteau T M; Bertín C P
    Rev Med Chil; 2007 Nov; 135(11):1421-8. PubMed ID: 18259653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allogeneic stem cell transplantation from related and unrelated donors for aplastic anaemia in adults--a single-centre experience.
    Buchholz S; Dammann E; Koenecke Ch; Stadler M; Franzke A; Blasczyk R; Bremer M; Krauter J; Hertenstein B; Ganser A; Eder M
    Ann Hematol; 2008 Jul; 87(7):551-6. PubMed ID: 18386010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe neonatal congenital erythropoietic porphyria.
    Hogeling M; Nakano T; Dvorak CC; Maguiness S; Frieden IJ
    Pediatr Dermatol; 2011; 28(4):416-20. PubMed ID: 21362030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The harvest and use of autologous back-up grafts for graft failure or severe GVHD after allogeneic hematopoietic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation.
    Stelljes M; van Biezen A; Slavin S; Olavarria E; Clark RE; Nagler A; Koza V; Kienast J; Niederwieser D; de Witte T; Ruutu T;
    Bone Marrow Transplant; 2008 Dec; 42(11):739-42. PubMed ID: 18724394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hematopoietic stem cell transplant for erythropoietic porphyrias in pediatric patients.
    Wang YM; Gloude NJ; Davies SM; Lucky AW; Nelson AS
    Pediatr Blood Cancer; 2021 Sep; 68(9):e29231. PubMed ID: 34245225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.